GO:1904383 response to sodium phosphate: Cellular Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904383 (response to sodium phosphate) describes any process by which a cell or organism changes its state or activity in response to a sodium phosphate stimulus [1, 5, 6].
• Sodium phosphate is a common buffer and food additive, but it also acts as a physiological stimulus that triggers rapid changes in gene expression, ion transport, and hormone secretion [1, 5, 7].
• Key organs involved include the intestine, kidney, and parathyroid gland, where phosphate sensing is critical for mineral homeostasis [1, 2, 5, 7].
• The response involves rapid regulation of phosphate transporters (e.g., SLC34A1, SLC34A2), the calcium-sensing receptor (CASR), and the hormone FGF23 [2, 5, 7].
• Dysregulated phosphate response contributes to chronic kidney disease, cardiovascular calcification, and metabolic bone disorders [2, 5, 7].
• CRISPR knockout, knock-in, and overexpression models are essential to dissect the causal roles of genes like NHE3, CASR, and FGF23 in this process [2, 5, 7].
Description
GO:1904383, response to sodium phosphate, is a biological process term that captures how cells and organisms react to a sodium phosphate stimulus. Sodium phosphate is not only a laboratory buffer but also a dietary and physiological stimulus that can rapidly alter cellular behavior, including ion transport, hormone secretion, and gene expression [1, 5, 6]. This term is crucial for researchers studying mineral metabolism, kidney function, and intestinal absorption because it provides a framework to understand how phosphate signals are sensed and integrated [1, 2, 5]. The response is highly conserved and involves multiple organ systems, making it a focal point for both basic and translational research [5, 7]. Understanding this process can illuminate mechanisms of diseases such as chronic kidney disease and cardiovascular calcification, where phosphate balance is disrupted [2, 7].
response to sodium phosphate At A Glance
| GO ID | GO:1904383 |
|---|---|
| GO term | response to sodium phosphate |
| Ontology | biological_process |
| Synonym | none |
| Major function | Cellular and organismal adaptation to sodium phosphate stimulus, including ion transport, hormone secretion, and gene expression changes |
| Related stimuli | Sodium phosphate (NaH2PO4/Na2HPO4), often used as a buffer or dietary phosphate source |
| Key organs | Intestine, kidney, parathyroid gland, bone |
| Key genes | SLC34A1, SLC34A2, CASR, FGF23, NHE3 (SLC9A3), PTH |
| Research relevance | Mineral homeostasis, chronic kidney disease, cardiovascular calcification, metabolic bone disease |
What Is GO:1904383?
According to the Gene Ontology, GO:1904383 (response to sodium phosphate) is defined as any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a sodium phosphate stimulus. In other words, it encompasses all molecular, cellular, and physiological changes triggered when a cell or organism encounters sodium phosphate, whether acutely or chronically [1, 5, 6].
Why Is response to sodium phosphate Important in Cell Biology?
The response to sodium phosphate is fundamental to maintaining phosphate homeostasis, which is essential for skeletal health, energy metabolism, and cellular signaling. Dysregulation of this response is implicated in a wide range of pathologies, including chronic kidney disease, cardiovascular calcification, and disorders of bone mineralization [2, 5, 7]. Studying GO:1904383 helps researchers identify the molecular sensors and effectors that mediate phosphate sensing, offering potential therapeutic targets for diseases characterized by phosphate imbalance [1, 5, 7].
• Maintains systemic phosphate balance, critical for bone mineralization and energy metabolism [5, 7].
• Regulates intestinal phosphate absorption and renal phosphate reabsorption [1, 2].
• Controls secretion of parathyroid hormone (PTH) and FGF23, key hormones in mineral homeostasis [5, 7].
• Influences cardiovascular health; excessive phosphate response contributes to vascular calcification.
• Plays a role in chronic kidney disease progression and complications [2, 5].
• Affects cellular processes such as apoptosis, proliferation, and differentiation in response to phosphate stress.
• Provides a model for studying rapid, non-genomic responses to ions.
• Relevant to sports science as sodium phosphate is used as an ergogenic aid.
• Involved in ocular pressure regulation, as shown by dexamethasone sodium phosphate studies [3, 4].
• Serves as a paradigm for understanding stimulus-response coupling in epithelial tissues [1, 6].
What Happens During response to sodium phosphate?
Sensing of Sodium Phosphate
In simple terms: Cells detect the presence of sodium phosphate through specific sensors or transporters.
The initial step in the response to sodium phosphate involves sensing the stimulus. In the kidney, the calcium-sensing receptor (CASR) has been shown to play a role in the acute response of renal phosphate transporters to phosphate intake, although this role appears to be parathyroid hormone-dependent. In the intestine, sodium phosphate can be sensed directly by enterocytes, leading to rapid changes in ion transport and gene expression. In bacteria such as Campylobacter jejuni, trisodium phosphate triggers a cellular response that includes changes in membrane integrity and gene expression.
Signal Transduction and Hormonal Regulation
In simple terms: The sensed phosphate signal is relayed inside the cell and throughout the body via hormones.
Upon sensing, signal transduction pathways are activated. FGF23, a hormone produced by osteocytes, is a key regulator of phosphate homeostasis and is secreted in response to phosphate load. FGF23 acts on the kidney to reduce phosphate reabsorption and on the parathyroid gland to inhibit PTH secretion. In the kidney, the sodium/proton exchanger NHE3 (SLC9A3) is involved in phosphate balance, as its genetic deletion in mice does not alter calcium and phosphate balance due to compensatory responses. These hormonal and transport adaptations are central to the response to sodium phosphate.
Cellular and Molecular Changes
In simple terms: Cells alter their gene expression, enzyme activity, and transport proteins to cope with the phosphate stimulus.
The response includes changes in gene expression, such as upregulation or downregulation of phosphate transporters (e.g., SLC34A1, SLC34A2) and enzymes involved in phosphate metabolism [1, 5]. In the intestine, acute intragastric or intravenous administration of phosphate in rats leads to rapid changes in the expression of genes related to phosphate transport and metabolism. In Campylobacter jejuni, exposure to trisodium phosphate results in differential expression of genes involved in stress response and membrane function.
Physiological Outcomes
In simple terms: The integrated response leads to changes in phosphate excretion, hormone levels, and overall mineral balance.
The ultimate outcome of the response to sodium phosphate is the maintenance of phosphate homeostasis. This involves increased renal excretion of phosphate when levels are high, mediated by reduced reabsorption in the proximal tubule [2, 5]. FGF23 and PTH coordinate this process by regulating the abundance of sodium-phosphate cotransporters in the kidney. In bone, phosphate is essential for mineralization, and the response to phosphate can influence bone remodeling. In sports science, sodium phosphate loading has been used as an ergogenic aid to improve performance, likely through effects on acid-base balance and energy metabolism.
Key Genes Involved in GO:1904383 response to sodium phosphate
The following genes and proteins are central to the response to sodium phosphate, based on experimental evidence from animal and cellular models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC34A1 | Renal sodium-phosphate cotransporter; mediates phosphate reabsorption | Target for studying renal phosphate handling and chronic kidney disease [2, 5] |
| SLC34A2 | Intestinal and renal sodium-phosphate cotransporter | Key for intestinal phosphate absorption and response to dietary phosphate |
| CASR | Calcium-sensing receptor; modulates PTH secretion and renal phosphate transport | Studied for its role in acute phosphate response |
| FGF23 | Hormone that reduces renal phosphate reabsorption and inhibits PTH | Central regulator of phosphate homeostasis; linked to chronic kidney disease |
| PTH | Parathyroid hormone; regulates renal phosphate reabsorption and bone remodeling | Key mediator of phosphate response [5, 7] |
| SLC9A3 (NHE3) | Sodium/proton exchanger; involved in renal and intestinal ion transport | Genetic deletion in mice reveals compensatory responses in phosphate balance |
| VDR | Vitamin D receptor; regulates phosphate and calcium absorption | Modulates response to phosphate via vitamin D signaling |
| FGFR1 | FGF receptor; mediates FGF23 signaling | Essential for FGF23 action in phosphate regulation |
| KL | Klotho; co-receptor for FGF23 | Required for FGF23 signaling in phosphate homeostasis |
| SLC20A1 | Type III sodium-phosphate cotransporter | Involved in cellular phosphate uptake and vascular calcification |
| SLC20A2 | Type III sodium-phosphate cotransporter | Linked to brain calcification and phosphate sensing |
| ALPL | Tissue-nonspecific alkaline phosphatase; hydrolyzes pyrophosphate | Plays a role in bone mineralization and phosphate metabolism |
| ENPP1 | Ectonucleotide pyrophosphatase/phosphodiesterase 1; generates pyrophosphate | Regulates phosphate balance and mineralization |
| CYP27B1 | 25-hydroxyvitamin D-1-alpha-hydroxylase; activates vitamin D | Regulated by phosphate and FGF23 |
| CYP24A1 | 24-hydroxylase; inactivates vitamin D | Feedback regulation by phosphate and FGF23 |
| GALNT3 | Polypeptide N-acetylgalactosaminyltransferase 3; O-glycosylates FGF23 | Mutations cause hyperphosphatemic familial tumoral calcinosis |
| SLC34A3 | Renal sodium-phosphate cotransporter; mutations cause hereditary hypophosphatemic rickets | Model for phosphate wasting disorders |
| SLC9A3R1 | Na+/H+ exchanger regulatory factor; interacts with NHE3 | Modulates phosphate transport in kidney |
How Is response to sodium phosphate Regulated?
The response to sodium phosphate is tightly regulated at multiple levels. Hormonal regulation involves FGF23 and PTH, which act on the kidney to control phosphate reabsorption. FGF23 secretion by osteocytes is stimulated by phosphate and active vitamin D, and it requires the co-receptor Klotho to signal through FGFR1. PTH secretion is inhibited by FGF23 and activated by low calcium, and PTH increases renal phosphate excretion by reducing the abundance of sodium-phosphate cotransporters [5, 7]. In the intestine, phosphate absorption is regulated by vitamin D and dietary phosphate levels. At the cellular level, the response involves rapid changes in transporter trafficking and gene expression, as well as feedback loops involving the calcium-sensing receptor. Additionally, NHE3 has been shown to have a role in phosphate balance, with compensatory mechanisms activated upon its deletion.
response to sodium phosphate and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FGF23 | Chronic kidney disease, tumor-induced osteomalacia | Knockout mouse, overexpression in osteocytes |
| CASR | Hypercalcemia, hypocalcemia, kidney stones | Point mutation knock-in mouse |
| SLC34A3 | Hereditary hypophosphatemic rickets with hypercalciuria | Knockout mouse, patient-derived iPSCs |
| NHE3 (SLC9A3) | Hypertension, intestinal phosphate absorption | Knockout mouse |
| GALNT3 | Hyperphosphatemic familial tumoral calcinosis | Knock-in mouse, overexpression |
Chronic Kidney Disease and Cardiovascular Calcification
In chronic kidney disease (CKD), the response to sodium phosphate is dysregulated, leading to hyperphosphatemia. Elevated phosphate levels stimulate FGF23 secretion, which initially helps maintain phosphate balance but eventually contributes to left ventricular hypertrophy and vascular calcification. The kidney's ability to excrete phosphate is impaired, and compensatory mechanisms involving NHE3 and other transporters may become insufficient. Targeting the phosphate response pathway, including FGF23 and its co-receptor Klotho, is a therapeutic strategy in CKD.
Metabolic Bone Diseases
Disorders of phosphate homeostasis, such as X-linked hypophosphatemia and tumor-induced osteomalacia, are characterized by excessive FGF23 activity, leading to renal phosphate wasting and defective bone mineralization. Mutations in SLC34A3 cause hereditary hypophosphatemic rickets with hypercalciuria, highlighting the importance of sodium-phosphate cotransporters in the response to phosphate. Understanding the response to sodium phosphate is essential for developing treatments for these conditions.
Ocular and Inflammatory Conditions
Sodium phosphate salts are used in ophthalmic formulations, such as dexamethasone sodium phosphate, which can affect ocular pressure [3, 4]. The response to sodium phosphate in the eye may involve changes in aqueous humor dynamics and inflammatory pathways [3, 4]. These studies underscore the broader physiological impact of sodium phosphate beyond mineral metabolism.
From response to sodium phosphate-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate renal phosphate excretion? | Knockout mouse (e.g., NHE3 KO) |
| Does a point mutation in CASR alter phosphate response? | Point mutation knock-in mouse |
| Can overexpression of FGF23 induce hypophosphatemia? | Transgenic overexpression mouse |
| What is the role of SLC34A2 in intestinal phosphate absorption? | Intestinal-specific knockout mouse |
| How does sodium phosphate affect bacterial gene expression? | Campylobacter jejuni deletion mutants |
| Does sodium phosphate loading improve athletic performance? | Human clinical trial with sodium phosphate supplementation |
How to Study the response to sodium phosphate Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify genes regulated by sodium phosphate [1, 6] |
| qPCR | Expression of specific genes | Validate SLC34A1, FGF23, CASR [5, 7] |
| Western blot | Protein abundance and phosphorylation | Assess transporter and signaling proteins |
| CRISPR knockout | Loss-of-function effects | Test causal role of NHE3 in phosphate balance |
| CRISPR knock-in | Point mutation effects | Model CASR mutations |
| Overexpression | Gain-of-function effects | Study FGF23 overexpression |
| Metabolic cages | Urine and serum phosphate levels | Measure renal phosphate excretion |
| Intravitreal injection | Ocular pressure response | Test dexamethasone sodium phosphate [3, 4] |
Animal Models and Physiological Measurements
Rodent models are widely used to study the response to sodium phosphate. Acute intragastric or intravenous administration of phosphate in rats allows measurement of intestinal and renal gene expression, serum phosphate, and hormone levels. Genetic knockout models, such as NHE3 KO mice, help dissect the contribution of specific transporters to phosphate balance. These models require careful monitoring of calcium and phosphate homeostasis.
Cell Culture and Bacterial Systems
Cellular responses to sodium phosphate can be studied in cultured cells, such as intestinal epithelial cells or kidney proximal tubule cells. For example, Campylobacter jejuni exposed to trisodium phosphate shows changes in gene expression and membrane integrity, which can be assessed by RNA-seq and proteomics. These systems allow controlled manipulation of phosphate concentration and time course.
Molecular and Genomic Techniques
RNA sequencing (RNA-seq) is used to identify global changes in gene expression in response to sodium phosphate [1, 6]. Quantitative PCR and Western blotting can validate specific targets, such as SLC34A1 or FGF23 [5, 7]. CRISPR-based gene editing enables the creation of knockout or knock-in cell lines to test the function of candidate genes in the phosphate response [2, 5].
Clinical and Translational Studies
Human studies, such as those using sodium phosphate as an ergogenic aid, provide insights into the physiological effects of phosphate loading. Ophthalmic studies with dexamethasone sodium phosphate assess ocular pressure responses, linking sodium phosphate to clinical outcomes [3, 4]. These studies require careful design to control for confounding factors like diet and renal function.
How CRISPR Can Be Used to Study GO:1904383 response to sodium phosphate
Knockout
CRISPR knockout is used to delete genes involved in the response to sodium phosphate, such as NHE3 (SLC9A3) in mice, to determine their role in phosphate balance. The NHE3 knockout mouse revealed compensatory responses that maintain calcium and phosphate homeostasis, highlighting the redundancy in the system. Knockout of SLC34A2 in intestinal cells can elucidate its role in phosphate absorption.
Point Mutation
Point mutations in genes like CASR can be introduced using CRISPR to model human diseases and study their impact on phosphate response. For example, mutations in CASR alter its sensitivity to calcium and phosphate, affecting PTH secretion and renal phosphate handling. These models are valuable for testing targeted therapies.
Knock-in
Knock-in of reporter genes or tagged alleles allows visualization and tracking of proteins involved in the phosphate response. For instance, tagging endogenous FGF23 with a fluorescent protein can help study its secretion dynamics in response to phosphate. Knock-in of human disease mutations, such as those in SLC34A3, can create accurate models of hypophosphatemic rickets.
Overexpression
Overexpression of genes like FGF23 in transgenic mice leads to hypophosphatemia and altered vitamin D metabolism, mimicking conditions of FGF23 excess. Overexpression of sodium-phosphate cotransporters in cell lines can increase phosphate uptake and reveal regulatory mechanisms. These models complement knockout studies by providing gain-of-function insights.
How EDITGENE Supports response to sodium phosphate Research
Researchers studying response to sodium phosphate-related genes often need to determine whether a candidate gene is causally involved in phosphate sensing, transport, or hormonal regulation. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and overexpression.
Contact EDITGENE today to design your custom CRISPR model for response to sodium phosphate research.
Frequently Asked Questions About response to sodium phosphate
What is GO:1904383?
GO:1904383 is the Gene Ontology term for 'response to sodium phosphate', defined as any process that results in a change in state or activity of a cell or organism as a result of a sodium phosphate stimulus [1, 5, 6].
What genes are involved in response to sodium phosphate?
Key genes include SLC34A1, SLC34A2, CASR, FGF23, PTH, and NHE3 (SLC9A3), which regulate phosphate transport and hormone secretion [2, 5, 7].
How does the kidney respond to sodium phosphate?
The kidney responds by adjusting phosphate reabsorption through transporters like SLC34A1 and SLC34A3, regulated by hormones such as FGF23 and PTH [2, 5, 7].
What is the role of FGF23 in phosphate response?
FGF23 is a hormone secreted by osteocytes that reduces renal phosphate reabsorption and inhibits PTH secretion, thereby lowering serum phosphate.
Can sodium phosphate affect athletic performance?
Sodium phosphate has been studied as an ergogenic aid, potentially improving performance through effects on acid-base balance and energy metabolism.
What diseases are linked to abnormal phosphate response?
Chronic kidney disease, cardiovascular calcification, and metabolic bone diseases like hypophosphatemic rickets are linked to dysregulated phosphate response [2, 5, 7].
How is the response to sodium phosphate studied in the lab?
Researchers use animal models, cell culture, RNA-seq, CRISPR knockout/knock-in, and physiological measurements of phosphate and hormones [1, 2, 5, 6].
What is the calcium-sensing receptor's role in phosphate response?
CASR modulates PTH secretion and renal phosphate transport, and its role in the acute response to phosphate intake is parathyroid hormone-dependent.
Does NHE3 affect phosphate balance?
Genetic deletion of NHE3 in mice does not alter calcium and phosphate balance due to compensatory responses, indicating redundancy in transport mechanisms.
How does sodium phosphate affect bacteria?
In Campylobacter jejuni, trisodium phosphate triggers a cellular response involving changes in gene expression and membrane integrity.
Conclusion
GO:1904383 (response to sodium phosphate) is a critical biological process that integrates sensing, signaling, and physiological adaptations to maintain phosphate homeostasis. Its dysregulation underlies major diseases such as chronic kidney disease and cardiovascular calcification. By leveraging CRISPR-based models and advanced omics, researchers can uncover novel therapeutic targets within this pathway. EDITGENE offers the tools and expertise to accelerate such discoveries.
References
- 1. Layunta E et al.. 2019. Intestinal Response to Acute Intragastric and Intravenous Administration of Phosphate in Rats.. Cell Physiol Biochem 52(4):838-849 PMID: 30946558
- 2. Poulsen SB et al.. 2025. Genetic deletion of the kidney sodium/proton exchanger-3 (NHE3) does not alter calcium and phosphate balance due to compensatory responses.. Kidney Int 107(2):280-295 PMID: 39089578
- 3. Lira RPC et al.. 2026. Intravitreal dexamethasone sodium phosphate challenge to predict implant response in refractory diabetic macular edema: a pilot study.. Arq Bras Oftalmol 89(3):e20250392 PMID: 42207107
- 4. Stewart RH et al.. 1984. Ocular pressure response to fluorometholone acetate and dexamethasone sodium phosphate.. Curr Eye Res 3(6):835-9 PMID: 6375979
- 5. Daryadel A et al.. 2024. The calcium-sensing receptor has only a parathyroid hormone-dependent role in the acute response of renal phosphate transporters to phosphate intake.. Am J Physiol Renal Physiol 326(5):F792-F801 PMID: 38545651
- 6. Riedel CT et al.. 2012. Cellular response of Campylobacter jejuni to trisodium phosphate.. Appl Environ Microbiol 78(5):1411-5 PMID: 22194296
- 7. Erben RG. 2017. Pleiotropic Actions of FGF23.. Toxicol Pathol 45(7):904-910 PMID: 29096595
- 8. Buck CL et al.. 2013. Sodium phosphate as an ergogenic aid.. Sports Med 43(6):425-35 PMID: 23568374
